AVNS logo

Avanos Medical Inc. (AVNS)

$24.80

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on AVNS

Market cap

$1.16B

EPS

-1.6

P/E ratio

--

Price to sales

1.65

Dividend yield

--

Beta

1.586279

Price on AVNS

Previous close

$24.77

Today's open

$24.80

Day's range

$24.76 - $24.81

52 week range

$9.30 - $24.81

Profile about AVNS

CEO

David C. Pacitti

Employees

2227

Headquarters

Alpharetta, GA

Exchange

New York Stock Exchange

Shares outstanding

46824793

Issue type

Common Stock

AVNS industries and sectors

Healthcare

Medical Equipment & Supplies

News on AVNS

AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down

Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.

news source

Zacks Investment Research • May 7, 2026

news preview

Avanos Medical, Inc. Announces First Quarter 2026 Results

Delivered double-digit organic growth led by Specialty Nutrition Systems segment Generated $0.11 of diluted earnings per share and $0.22 of adjusted diluted earnings per share On April 14, 2026, announced the execution of a definitive agreement to be acquired by certain affiliates of American Industrial Partners ("AIP") in an all-cash offer at an enterprise value of $1.272 billion ALPHARETTA, Ga., May 5, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2026 financial results.

news source

PRNewsWire • May 5, 2026

news preview

Avanos Medical (AVNS) Lags Q1 Earnings Estimates

Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.26 per share a year ago.

news source

Zacks Investment Research • May 5, 2026

news preview

Shareholder Alert: Ademi LLP investigates whether Avanos Medical Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE, April 23, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Avanos (NYSE: AVNS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with American Industrial.

news source

GlobeNewsWire • Apr 23, 2026

news preview

Top 2 Health Care Stocks That May Fall Off A Cliff In Q2

As of April 17, 2026, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

news source

Benzinga • Apr 17, 2026

news preview

Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is seeking to determine whether this consideration and the process that le.

news source

Business Wire • Apr 15, 2026

news preview

Avanos Stock Surged on $1.27 Billion AIP Buyout Deal at 72% Premium

AVNS stock jumps after agreeing to a $1.27B all-cash buyout by AIP at a 72% premium, offering shareholders immediate value and setting up a private-market shift.

news source

Zacks Investment Research • Apr 15, 2026

news preview

AIP to take Avanos Medical private in a deal valued at about $1.27 billion

Avanos ​Medical said ‌on Tuesday ​it ​has agreed ⁠to ​be ​bought by affiliates ​of ​American Industrial Partners (AIP) ‌in ⁠an all-cash ​deal ​worth ⁠about $1.27 billion.

news source

Reuters • Apr 14, 2026

news preview

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avanos Medical, Inc. (NYSE: AVNS)

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Avanos Medical, Inc. (NYSE:  AVNS )  related to its sale to affiliates of American Industrial Partners.

news source

GlobeNewsWire • Apr 14, 2026

news preview

Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion

Avanos Stockholders To Receive $25.00 Per Share in Cash ALPHARETTA, Ga. and NEW YORK, April 14, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced it has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners ("AIP"), an operationally-oriented industrials investor, in an all-cash transaction that values Avanos at an enterprise value of approximately $1.272 billion.

news source

PRNewsWire • Apr 14, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Avanos Medical Inc.

Open an M1 investment account to buy and sell Avanos Medical Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in AVNS on M1